Each year members of the industry gather together at Dpharm — a conference which challenges attendees to question how we, as an industry, can disrupt clinical research to reduce the burden to patients and physicians. This year's event will be held virtually September 28-29 and will focuses on making innovation stick in a post-COVID world.
DPharm. It's one of my favorite conferences that I look forward to each year. This year we will be virtual September 22-23, but still the same great energy and excitement. DPharm is a standout event that challenges and reports on innovation, with the goal of shaking up the way we conduct clinical trials so that we can reduce patient / physician burden and create greater efficiencies.
While most large pharma companies seem “very open” to new technologies, a recent FiercePharma article also notes that the life science industry hasn’t exactly won accolades for its speed in adopting new artificial intelligence and machine learning technologies. However, since patient lives are at stake, the industry has good reason to proceed with caution.*
Dena Raffa, Director, Account Operations and BBK’s expert in digital innovation, shares her view on the complex topic of AI and machine learning technologies in life sciences.
Pharma15 Live! jumped at the chance to hear SnapIoT’s Ed Triebell discuss his company’s ground-breaking product, a software platform which allows users to seamlessly connect any smart device to any mobile device—and to any cloud.
Pharma15 Live! simply could not resist speaking with Jae Chung, founder of the “Turbo Tax for clinical trials start-up,” goBalto - and his furry friend, the Siberian Husky puppy aptly named Balto. Chung discussed his company’s mission to automate the laborious manual processes related to clinical trial start-up.
Georgia Mitsi spoke with BBK Worldwide®’s Aaron Fleishman about her company’s newest app E.V.A — an engagement platform for patients who suffer from chronic neurological conditions. Says Mitsi: “It’s about evaluate, validate and act.”
During this year’s DPharm 2018, Pharma15 Live! met up with Hassan Kadhim, senior associate director and head of IT clinical trial planning and management at Boehringer Ingelheim, before his presentation on the company’s novel remote clinical trial in the respiratory space. Kadhim reflected about the huge changes that he’s seen in the industry just in the past year.
Pharma15 Live! sat down Valerie Bowling, drug development industry researcher and founder of DPharm, during the conference to discuss this year’s presentations, and the very popular DPharm Idol competition: